Agostino Cortelezzi

10.4k total citations
189 papers, 4.2k citations indexed

About

Agostino Cortelezzi is a scholar working on Genetics, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, Agostino Cortelezzi has authored 189 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 97 papers in Genetics, 95 papers in Hematology and 42 papers in Pathology and Forensic Medicine. Recurrent topics in Agostino Cortelezzi's work include Chronic Lymphocytic Leukemia Research (63 papers), Acute Myeloid Leukemia Research (46 papers) and Lymphoma Diagnosis and Treatment (33 papers). Agostino Cortelezzi is often cited by papers focused on Chronic Lymphocytic Leukemia Research (63 papers), Acute Myeloid Leukemia Research (46 papers) and Lymphoma Diagnosis and Treatment (33 papers). Agostino Cortelezzi collaborates with scholars based in Italy, United States and Germany. Agostino Cortelezzi's co-authors include Wilma Barcellini, Giorgio Lambertenghi‐Deliliers, Elisa Fermo, Nicola Fracchiolla, Antonino Neri, Bruno Fattizzo, Giorgio La Nasa, Anna Zaninoni, Alberto Zanella and Paola Bianchi and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Agostino Cortelezzi

180 papers receiving 4.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Agostino Cortelezzi Italy 36 2.0k 1.8k 1.1k 891 825 189 4.2k
Rosangela Invernizzi Italy 31 3.7k 1.9× 2.4k 1.3× 1.5k 1.4× 378 0.4× 337 0.4× 157 5.2k
Chin‐Yang Li United States 36 1.2k 0.6× 1.5k 0.9× 1.1k 1.1× 710 0.8× 1.4k 1.7× 125 4.2k
Jean‐Paul Fermand France 34 1.8k 0.9× 890 0.5× 2.3k 2.1× 445 0.5× 792 1.0× 105 4.4k
Attilio Olivieri Italy 33 2.2k 1.1× 680 0.4× 568 0.5× 580 0.7× 801 1.0× 156 3.6k
Gian Matteo Rigolin Italy 30 831 0.4× 1.1k 0.6× 904 0.8× 764 0.9× 693 0.8× 117 2.8k
Matteo Giovanni Della Porta Italy 43 5.3k 2.7× 3.7k 2.1× 2.0k 1.8× 668 0.7× 711 0.9× 193 7.5k
Luca Malcovati Italy 47 5.9k 3.0× 3.8k 2.1× 2.1k 1.9× 600 0.7× 573 0.7× 187 7.5k
Richard K. Burt United States 42 1.7k 0.9× 1.1k 0.6× 1.0k 0.9× 2.6k 2.9× 2.0k 2.4× 167 6.9k
Pei Lin United States 40 2.0k 1.0× 1.9k 1.1× 1.7k 1.5× 2.2k 2.5× 842 1.0× 224 5.4k
Uday Popat United States 43 4.0k 2.0× 1.5k 0.9× 1.3k 1.2× 973 1.1× 1.3k 1.6× 396 6.6k

Countries citing papers authored by Agostino Cortelezzi

Since Specialization
Citations

This map shows the geographic impact of Agostino Cortelezzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Agostino Cortelezzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Agostino Cortelezzi more than expected).

Fields of papers citing papers by Agostino Cortelezzi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Agostino Cortelezzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Agostino Cortelezzi. The network helps show where Agostino Cortelezzi may publish in the future.

Co-authorship network of co-authors of Agostino Cortelezzi

This figure shows the co-authorship network connecting the top 25 collaborators of Agostino Cortelezzi. A scholar is included among the top collaborators of Agostino Cortelezzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Agostino Cortelezzi. Agostino Cortelezzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bosch, Francesc, Guy Cantin, Agostino Cortelezzi, et al.. (2019). Obinutuzumab plus fludarabine and cyclophosphamide in previously untreated, fit patients with chronic lymphocytic leukemia: a subgroup analysis of the GREEN study. Leukemia. 34(2). 441–450. 6 indexed citations
2.
3.
Barcellini, Wilma, Bruno Fattizzo, Anna Zaninoni, et al.. (2017). Healthcare Resource Utilization in Autoimmune Hemolytic Anemia Patients: Analysis of 190 Cases from a Single Center. Blood. 130. 3370–3370. 2 indexed citations
4.
Autore, Francesco, Paolo Strati, Idanna Innocenti, et al.. (2016). LDH Levels Predict Progression-Free Survival in Treatment-NaÏVe Patients with Trisomy 12 Chronic Lymphocytic Leukemia. Blood. 128(22). 3211–3211. 2 indexed citations
5.
Iurlo, Alessandra, Umberto Gianelli, Alessandro Beghini, et al.. (2014). Identification of kitM541L somatic mutation in chronic eosinophilic leukemia, not otherwise specified and its implication in low-dose imatinib response. Oncotarget. 5(13). 4665–4670. 23 indexed citations
6.
Visco, Carlo, Agostino Cortelezzi, Francesca Moretta, et al.. (2013). Autoimmune cytopenias in chronic lymphocytic leukemia at disease presentation in the modern treatment era: is stage C always stage C?. Leukemia & lymphoma. 55(6). 1261–1265. 12 indexed citations
7.
Barcellini, Wilma, Francesca Guia Imperiali, Anna Zaninoni, et al.. (2013). Toll-like receptor 4 and 9 expression in B-chronic lymphocytic leukemia: relationship with infections, autoimmunity and disease progression. Leukemia & lymphoma. 55(8). 1768–1773. 17 indexed citations
8.
Visco, Carlo, Francesco Maura, Giacomo Tuana, et al.. (2012). Immune Thrombocytopenia in Patients with Chronic Lymphocytic Leukemia Is Associated with Stereotyped B-cell Receptors. Clinical Cancer Research. 18(7). 1870–1878. 20 indexed citations
9.
10.
Bianchi, Paola, Elisa Fermo, Cristina Vercellati, et al.. (2011). Diagnostic power of laboratory tests for hereditary spherocytosis: a comparison study in 150 patients grouped according to molecular and clinical characteristics. Haematologica. 97(4). 516–523. 125 indexed citations
11.
Ricci, Clara, Elisa Fermo, Stefania Corti, et al.. (2010). RAS Mutations Contribute to Evolution of Chronic Myelomonocytic Leukemia to the Proliferative Variant. Clinical Cancer Research. 16(8). 2246–2256. 99 indexed citations
12.
Bassan, R, Tamara Intermesoli, Elena Oldani, et al.. (2008). Short-course imatinib (IM) added to chemotherapy improves early but not long-term outcome in adult Ph/BCR-ABL+ acute lymphoblastic leukemia (ALL) : 5-year follow-up results of study NILG-09. Haematologica. 93. 366–367. 4 indexed citations
13.
Cortelezzi, Agostino, Umberto Gianelli, Barbara Sarina, et al.. (2006). Low dose campath 1-H is highly effective and safe in advanced chronic CLL. Haematologica. 91. 76–76. 1 indexed citations
14.
Fermo, Elisa, Paola Bianchi, Wilma Barcellini, et al.. (2004). Immunoregulatory cytokine polymorphisms in Italian patients affected by paroxysmal nocturnal haemoglobinuria and aplastic anaemia. European Journal of Immunogenetics. 31(6). 267–269. 20 indexed citations
15.
Cro, Lilla, Andrea Guffanti, Marina Colombi, et al.. (2003). Diagnostic role and prognostic significance of a simplified immunophenotypic classification of mature B cell chronic lymphoid leukemias. Leukemia. 17(1). 125–132. 18 indexed citations
16.
Pruneri, Giancarlo, D. Soligo, Nadia Carboni, et al.. (1998). Angiogenesis in myelodysplastic syndromes. Analysis of 59 cases.. Blood. 92. 1 indexed citations
17.
Cantù-Rajnoldi, A, A B Federici, Andrea Biondi, et al.. (1994). Acute promyelocytic leukemia with unusual morphological features, absence of the t(15,17) and rearranged PML/RAR alpha genes.. PubMed. 79(3). 294–6. 1 indexed citations
18.
Lambertenghi‐Deliliers, Giorgio, C. Annaloro, Agostino Cortelezzi, et al.. (1989). Idarubicin plus cytarabine as first-line treatment of acute nonlymphoblastic leukemia.. PubMed. 16(1 Suppl 2). 16–20. 9 indexed citations
19.
Scheithauer, Werner, et al.. (1987). VAD protocol for treatment of advanced refractory multiple myeloma. Annals of Hematology. 55(3). 145–152. 5 indexed citations
20.
Ludwig, Heinz, Agostino Cortelezzi, E Polli, et al.. (1985). Treatment with Recombinant Interferon-Alpha-2C: Multiple Myeloma and Thrombocythaemia in Myeloproliferative Diseases. Oncology. 42(1). 19–25. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rosangela Invernizzi Breakdown of academic impact, for papers by Chin‐Yang Li Breakdown of academic impact, for papers by Jean‐Paul Fermand Breakdown of academic impact, for papers by Attilio Olivieri Breakdown of academic impact, for papers by Gian Matteo Rigolin Breakdown of academic impact, for papers by Matteo Giovanni Della Porta Breakdown of academic impact, for papers by Luca Malcovati Breakdown of academic impact, for papers by Richard K. Burt Breakdown of academic impact, for papers by Pei Lin Breakdown of academic impact, for papers by Uday Popat
Rankless by CCL
2026